NASDAQ: RACDResearch Alliance Corp IV Stock
$10.50-0.14 (-1.32%)
Updated Jul 16, 2026
RACD Price
$10.50
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$10.31
52 Week High
$11.65
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0
Operating Cash Flow
N/A
Beta
3.11
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
RACD Overview
Research Alliance Corp. IV is a blank check company. It was created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on April 1, 2026 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine RACD's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
RACD
Ranked#16 of 39
Ranked#16 of 39
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.77 | C | |
| $11.80 | C | |
| $10.08 | C |
Be the first to know about important RACD news, forecast changes, insider trades & much more!
RACD News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RACD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RACD's debt to equity ratio (0) is considered acceptable
Healthy Debt to Equity Financials
Insufficient data to perform Discounted Cash Flow valuation for RACD
Below Fair Value Valuation
Insufficient data to perform Discounted... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
There are 30 more RACD due diligence checks available for Premium users.
Valuation
RACD's financial health
Profit margin
Revenue
$0.0
Net Income
-$14.5k
Profit Margin
0%
Assets to liabilities
Assets
$10.5k
Liabilities
$0.0
Debt to equity
0
RACD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$0.0
Investing
$0.0
Financing
$0.0
Research Alliance IV Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.